減価償却費、減損損失 - 医薬品開発支援、貸倒引当金繰入額他1件
- 【期間】
| 年度 | 減価償却費 | 減損損失 - 医薬品開発支援 | 貸倒引当金繰入額 | 建物及び構築物 |
|---|
| 2008/03 | - | | - | | - | | 48.5億 | |
| 2009/03 | - | | - | | - | | 52.7億 | +8.7% |
| 2010/03 | - | | - | | - | | 55.2億 | +4.7% |
| 2011/03 | - | | - | | - | | 56.8億 | +2.9% |
| 2012/03 | - | | - | | - | | 61.3億 | +7.8% |
| 2013/03 | 69百万 | | - | | - | | 62.3億 | +1.8% |
| 2014/03 | 38百万 | -45% | - | | - | | 63.4億 | +1.7% |
| 2015/03 | - | | 139百万 | | - | | 55.2億 | -12.9% |
| 2016/03 | - | | - | | - | | 58.4億 | +5.8% |
| 2017/03 | - | | - | | - | | 59億 | +1% |
| 2018/03 | - | | - | | - | | 59.4億 | +0.6% |
| 2019/03 | - | | - | | - | | 58.9億 | -0.8% |
| 2020/06 | - | | - | | - | | 60.2億 | +2.3% |
| 2021/06 | - | | - | | 208百万 | | 60.1億 | -0.3% |
| 2022/06 | - | | - | | 80百万 | -61.8% | 61.8億 | +2.9% |
| 2023/06 | - | | - | | 307百万 | +286.2% | 63.2億 | +2.2% |
